Afya Ltd
No SEC Form 4 filings for $AFYA in the last 30 days.
See all $AFYA insider activity →Afya Limited (AFYA) agreed to merge into YDUQS, with Afya shareholders receiving YDUQS shares at a fixed 6.408347 ratio and expected to own 69% of the combined company. The deal is subject to approvals, including CADE and EGMs.
Afya and Yduqs, Brazil's largest medical-education network and education group, confirmed early-stage merger talks on 24 August 2026. Yduqs shares rose 12.1% in São Paulo, while Afya's shares in New York increased 0.77%. The companies' second-quarter financials showed contrasting performances, with Afya in a stronger position. No binding agreements or details have been finalized, and both companies emphasized the preliminary nature of the discussions.
Afya (AFYA) reported Q2 2026 revenue of BRL 1.985 billion, up 7% YoY. Adjusted EBITDA rose 3% to BRL 918 million, while net income increased 7% to BRL 463 million. The company faces AI competition in clinical decision tools but is integrating AI into its iClinic platform. Management reaffirmed its full-year EBITDA guidance of BRL 1.7-1.8 billion.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AFYA (Afya Ltd). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent AFYA coverage spans earnings, insider activity and mergers & acquisitions.
Afya Limited (AFYA) agreed to merge into YDUQS, with Afya shareholders receiving YDUQS shares at a fixed 6.408347 ratio and expected to own 69% of the combined company. The deal is subject to approvals, including CADE and EGMs.
Afya may become senior partner in a combined education giant.
Earnings beat on revenue and net income with modest margin pressure; guidance reaffirmed suggests stable outlook.
Guidance is maintained, but management flagged AI pressure on Whitebook active payers and outlined price cuts plus product investment to recover.
The print is a small EPS and revenue miss, so near-term trading likely hinges on management commentary and any changes to estimate revisions.
AlphAI scores every news story that mentions AFYA with an AI model for sentiment and relevance, and aggregates insider trades from Afya Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Afya Limited (AFYA) agreed to merge into YDUQS, with Afya shareholders receiving YDUQS shares at a fixed 6.408347 ratio and expected to own 69% of the combined company. The deal is subject to approvals, including CADE and EGMs.
2 min readAfya and Yduqs, Brazil's largest medical-education network and education group, confirmed early-stage merger talks on 24 August 2026. Yduqs shares rose 12.1% in São Paulo, while Afya's shares in New York increased 0.77%. The companies' second-quarter financials showed contrasting performances, with Afya in a stronger position. No binding agreements or details have been finalized, and both companies emphasized the preliminary nature of the discussions.
2 min readAfya (AFYA) reported Q2 2026 revenue of BRL 1.985 billion, up 7% YoY. Adjusted EBITDA rose 3% to BRL 918 million, while net income increased 7% to BRL 463 million. The company faces AI competition in clinical decision tools but is integrating AI into its iClinic platform. Management reaffirmed its full-year EBITDA guidance of BRL 1.7-1.8 billion.
3 min readAfya (NASDAQ:AFYA) reported Q2 earnings call updates. Management said medical course pricing stayed favorable and health science courses grew 13% YoY. Continuing education revenue rose 5% to BRL 144 million; medical practice solutions revenue rose 2% to BRL 85 million. Operating cash flow was BRL 806 million and free cash flow to equity BRL 423 million. Full-year adjusted EBITDA guidance was kept at BRL 1.7-1.8 billion.
4 min readAfya (AFYA) reported Q2 adjusted EPS of $0.45, slightly below the Zacks Consensus of $0.46, versus $0.40 a year earlier. Revenue was $192.36 million, marginally under the estimate. The article cites a Zacks Rank #3 (Hold) and notes upcoming consensus for the next quarter at $0.41 EPS on $196.33 million revenue.
4 min readAfya Ltd (AFYA) furnished an SEC Form 6-K — earnings release. Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results R$448 Million Returned to Shareholders 106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases Belo Horizonte, Brazil, August 13, 2026 – Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or th
2 min readAfya Limited (Nasdaq: AFYA) announced that Marcelo Ken Suhara was appointed on July 27, 2026 as Chair Member of its Audit, Risks and Ethics Committee. He succeeds João Paulo Seibel de Faria, whose passing was noted by the company. Afya said Suhara will continue as Audit Committee financial expert and independent board member.
2 min readJunior Lelio de Souza (Vice President) sold 36,204 shares of Afya Ltd (AFYA) at $15.00 ($0.54M total) on 2026-07-01.
1 min readBasolli Gomiero Mirella (Vice President) sold 10,000 shares of Afya Ltd (AFYA) at $14.80 ($0.15M total) on 2026-06-26.
2 min readJunior Lelio de Souza (Vice President) sold 41,541 shares of Afya Ltd (AFYA) at $15.00 ($0.62M total) on 2026-06-26.
2 min read
